Potential of antibody–drug conjugates and novel therapeutics in breast cancer management

Potential of antibody–drug conjugates and novel therapeutics in breast cancer management

Georgios D Lianos,1 Konstantinos Vlachos,2 Odysseas Zoras,3 Christos Katsios,1 William C Cho,4 Dimitrios H Roukos11Centre for Biosystems and Genomic Network Medicine, Ioannina University, Ioannina, Greece; 2Department of Surgery, Ioannina University Hospital, Ioannina, Greece; 3Department of Surgic...

Full description

Bibliographic Details
Main Authors:	Lianos GD, Vlachos K, Zoras O, Katsios C, Cho WC, Roukos DH
Format:	Article
Language:	English
Published:	Dove Medical Press 2014-03-01
Series:	OncoTargets and Therapy
Online Access:	http://www.dovepress.com/potential-of-antibodyndashdrug-conjugates-and-novel-therapeutics-in-br-a16194

Similar Items

Intracellular trafficking of new anticancer therapeutics: antibody–drug conjugates
by: Kalim M, et al.
Published: (2017-08-01)

Antibody Drug Conjugates as Cancer Therapeutics
by: Pamela A. Trail
Published: (2013-02-01)

Microtubule inhibitor-based antibody–drug conjugates for cancer therapy
by: Klute K, et al.
Published: (2014-12-01)

Antibody Conjugation of Nanoparticles as Therapeutics for Breast Cancer Treatment
by: Alberto Juan, et al.
Published: (2020-08-01)

Novel antibody–drug conjugates for triple negative breast cancer
by: Aiko Nagayama, et al.
Published: (2020-05-01)

Antibody-Drug Conjugates Used in Breast Cancers
by: Aram J. Abbas, et al.
Published: (2021-01-01)

Antibody–Drug Conjugates for the Treatment of Breast Cancer
by: Chiara Corti, et al.
Published: (2021-06-01)

Polymer-Drug Conjugate, a Potential Therapeutic to Combat Breast and Lung Cancer
by: Sibusiso Alven, et al.
Published: (2020-04-01)

Therapeutic Potential of Antibody-Drug Conjugate-Based Therapy in Head and Neck Cancer: A Systematic Review
by: Vittoria Perrotti, et al.
Published: (2021-06-01)

Antibody-Oligonucleotide Conjugates: A Twist to Antibody-Drug Conjugates
by: Julien Dugal-Tessier, et al.
Published: (2021-02-01)

Targeting Vesicular LGALS3BP by an Antibody-Drug Conjugate as Novel Therapeutic Strategy for Neuroblastoma
by: Emily Capone, et al.
Published: (2020-10-01)

Antibody-drug conjugates with dual payloads for combating breast tumor heterogeneity and drug resistance
by: Chisato M. Yamazaki, et al.
Published: (2021-06-01)

Functional relevance of in vivo half antibody exchange of an IgG4 therapeutic antibody-drug conjugate.
by: Peter Herbener, et al.
Published: (2018-01-01)

Monoclonal Antibodies and Antibody Drug Conjugates in Multiple Myeloma
by: Jakub Radocha, et al.
Published: (2021-03-01)

Antibody–Drug Conjugates for Cancer Therapy
by: Umbreen Hafeez, et al.
Published: (2020-10-01)

Antibody–Drug Conjugates: The Last Decade
by: Nicolas Joubert, et al.
Published: (2020-09-01)

Antibody Drug Conjugates for Cancer Therapy
by: S M Gheibi hayat, et al.
Published: (2017-07-01)

Acquired Resistance to Antibody-Drug Conjugates
by: Denis M. Collins, et al.
Published: (2019-03-01)

Antibody–Drug Conjugates for Cancer Therapy
by: Adam C. Parslow, et al.
Published: (2016-07-01)

Antibody–Drug Conjugate to Treat Meningiomas
by: Kai Chen, et al.
Published: (2021-05-01)

Clinical Pharmacology of Antibody-Drug Conjugates
by: Iftekhar Mahmood
Published: (2021-05-01)

Pyrrolobenzodiazepine Antibody-Drug Conjugates Designed for Stable Thiol Conjugation
by: R. James Christie, et al.
Published: (2017-11-01)

HER2 Directed Antibody-Drug-Conjugates beyond T-DM1 in Breast Cancer
by: Gabriel Rinnerthaler, et al.
Published: (2019-03-01)

Potential therapeutic hazards due to drug–drug interaction between topically and systemically coadministered medications
by: Lan MJ, et al.
Published: (2013-07-01)

Co-administered antibody improves penetration of antibody–dye conjugate into human cancers with implications for antibody–drug conjugates
by: Guolan Lu, et al.
Published: (2020-11-01)

Treating Prostate Cancer by Antibody-Drug Conjugates
by: Matteo Rosellini, et al.
Published: (2021-02-01)

An overview of antibody–drug conjugates in oncological practice
by: Charalampos Theocharopoulos, et al.
Published: (2020-10-01)

Antibody-Drug Conjugates: The New Frontier of Chemotherapy
by: Sara Ponziani, et al.
Published: (2020-07-01)

Current status of antibody-drug conjugate bioanalysis
by: Jian Wang
Published: (2017-04-01)

Factors Affecting the Pharmacology of Antibody–Drug Conjugates
by: Andrew T. Lucas, et al.
Published: (2018-02-01)

Fate of Antibody-Drug Conjugates in Cancer Cells
by: Cécile Chalouni, et al.
Published: (2018-02-01)

Generation of Antibody-Drug Conjugate Resistant Models
by: Lucía Gandullo-Sánchez, et al.
Published: (2021-09-01)

Advances and Limitations of Antibody Drug Conjugates for Cancer
by: Candice Maria Mckertish, et al.
Published: (2021-07-01)

Antibody–Drug Conjugates—A Tutorial Review
by: Stephanie Baah, et al.
Published: (2021-05-01)

Pharmacometric Models for Antibody Drug Conjugates and Taxanes in HER2+ and HER2- Breast Cancer
by: Bender, Brendan
Published: (2016)

A Polar Sulfamide Spacer Significantly Enhances the Manufacturability, Stability, and Therapeutic Index of Antibody–Drug Conjugates
by: Jorge M. M. Verkade, et al.
Published: (2018-02-01)

Drug Conjugates Such as Antibody Drug Conjugates (ADCs), Immunotoxins and Immunoliposomes Challenge Daily Clinical Practice
by: Christoph Mamot, et al.
Published: (2012-11-01)

Antibody Drug Conjugate Bioinformatics: Drug Delivery through the Letterbox
by: Dimitrios Vlachakis, et al.
Published: (2013-01-01)

Novel nanosized AS1411–chitosan–BODIPY conjugate for molecular fluorescent imaging
by: Taki S, et al.
Published: (2019-05-01)

Gastric Volvulus and Wandering Spleen: A Rare Surgical Emergency
by: Georgios Lianos, et al.
Published: (2013-01-01)

Cannot write session to /tmp/vufind_sessions/sess_5kjnold663a6nv2jcdrom13gjd